Has the first treatment of type 2 diabetes mellitus changed?

被引：0
作者：
Flores, Lilliam [1 ]
Vidal, Josep [1 ]
机构：
[1] Hosp Clin Barcelona, Serv Endocrinol Nutr, Unidad Obes, Barcelona, Spain
来源：
MEDICINA CLINICA | 2024年 / 163卷 / 10期
关键词：
CARDIOVASCULAR OUTCOMES; HEART-FAILURE; METAANALYSIS; MORTALITY; DISEASE; RISK;
D O I：
10.1016/j.medcli.2024.05.016
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：509 / 511
页数：3
相关论文
共 50 条
  • [41] Physical exercise as treatment of type 2 diabetes mellitus
    Koenig, D.
    Berg, A.
    INTERNIST, 2012, 53 (06): : 678 - 687
  • [42] Timing of randomization after an acute coronary syndrome in patients with type 2 diabetes mellitus
    Elharram, Malik
    Sharma, Abhinav
    White, William
    Bakris, George
    Rossignol, Patrick
    Mehta, Cyrus
    Ferreira, Joao Pedro
    Zannad, Faiez
    AMERICAN HEART JOURNAL, 2020, 229 : 40 - 51
  • [43] Stroke Prevention by Antihyperglycemic Drugs in Type 2 Diabetes Mellitus
    Albert, Stewart G.
    Shrestha, Ekta
    Ahir, Vaishaliben
    ENDOCRINE PRACTICE, 2024, 30 (03) : 246 - 252
  • [44] Saxagliptin and Cardiovascular Outcomes in Patients with Type 2 Diabetes Mellitus
    Scirica, Benjamin M.
    Bhatt, Deepak L.
    Braunwald, Eugene
    Steg, P. Gabriel
    Davidson, Jaime
    Hirshberg, Boaz
    Ohman, Peter
    Frederich, Robert
    Wiviott, Stephen D.
    Hoffman, Elaine B.
    Cavender, Matthew A.
    Udell, Jacob A.
    Desai, Nihar R.
    Mosenzon, Ofri
    McGuire, Darren K.
    Ray, Kausik K.
    Leiter, Lawrence A.
    Raz, Itamar
    Braunwald, Eugene
    Bhatt, Deepak L.
    Scirica, Benjamin M.
    Udell, Jacob A.
    Cavender, Matthew A.
    Desai, Nihar
    Abrahamsen, Timothy
    Grossman, Michelle
    Morin, Suzanne
    Im, Kyungah
    Hoffman, Elaine
    Gabovitch, Daniel
    Pricken, Alexandra
    Mosenzon, Ofri
    Buskila, Alona
    Ohman, Peter
    Hirshberg, Boaz
    Stahre, Christina
    Price, Deborah
    Billing-Clason, Solveig
    Sabel, Karin
    Monyak, John
    Sjostrand, Mikalea
    Wei, Cheryl
    Lu, Jane
    Miller, Elinor
    Raichlen, Joel
    Fitt, Sandy
    Frederich, Robert
    Iqbal, Nayyar
    Donovan, Mark
    Davidson, Jaime A.
    NEW ENGLAND JOURNAL OF MEDICINE, 2013, 369 (14) : 1317 - 1326
  • [45] Sodium-glucose transporter-2 inhibitors for prevention and treatment of cardiorenal complications of type 2 diabetes
    Giugliano, Dario
    Longo, Miriam
    Scappaticcio, Lorenzo
    Caruso, Paola
    Esposito, Katherine
    CARDIOVASCULAR DIABETOLOGY, 2021, 20 (01)
  • [46] Making sense of newer treatment options for type 2 diabetes
    Lee, Phong Ching
    Hare, Matthew J. L.
    Bach, Leon A.
    INTERNAL MEDICINE JOURNAL, 2018, 48 (07) : 762 - 769
  • [47] Glycaemic Control and Vascular Complications in Diabetes Mellitus Type 2
    Maranta, Francesco
    Cianfanelli, Lorenzo
    Cianflone, Domenico
    DIABETES: FROM RESEARCH TO CLINICAL PRACTICE, VOL 4, 2021, 1307 : 129 - 152
  • [48] Executive summary: Updates to the dietary treatment of prediabetes and type 2 diabetes mellitus
    Pascual Fustera, V
    Perez Perez, A.
    Carretero Gomez, J.
    Caixas Pedragos, A.
    Gomez-Huelgas, R.
    Perez-Martinez, P.
    REVISTA CLINICA ESPANOLA, 2021, 221 (03): : 169 - 179
  • [49] Glycemic index and glycemic load in the prevention and treatment of type 2 diabetes mellitus
    Silva, Flavia Moraes
    Steemburgo, Thais
    de Azevedo, Mirela J.
    de Mello, Vanessa D.
    ARQUIVOS BRASILEIROS DE ENDOCRINOLOGIA E METABOLOGIA, 2009, 53 (05) : 560 - 571
  • [50] The societal impact of early intensified treatment in patients with type 2 diabetes mellitus
    Tsotra, Foteini
    Kappel, Mathias
    Peristeris, Platon
    Bader, Giovanni
    Levi, Eva
    Lister, Nicola
    Malhotra, Ankur
    Ostwald, Dennis A.
    JOURNAL OF COMPARATIVE EFFECTIVENESS RESEARCH, 2022, 11 (16) : 1185 - 1199
12345